ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On November 9, 2020, Pulse Biosciences, Inc. announced its financial results for the three- and nine-months ended September 30, 2020. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

This information, as well as Exhibit 99.1, is intended to be furnished under Item 2.02 of Form 8-K, "Results of Operations and Financial Condition" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

     (d)                                  Exhibits.

 Exhibit No.                              Description
    99.1                                  Press Release issued by Pulse Biosciences, Inc.
                                          dated November 9, 2020.




?

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses